Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 465
Selected: 0
NCT IDTitle
NCT06165809A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer
NCT05487976Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With Inhibitor
NCT03703596Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLC
NCT04355520A Study of TQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer
NCT07179679A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell Tumors
NCT07545213Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis
NCT05013697TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.
NCT04964479A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC)
NCT06089278A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps.
NCT07044908TQB2922 and TAS-102 Tablets for Injection With or Without Bevacizumab in Chemotherapy-failed RAS/BRAF Wild-type Advanced Colorectal Cancer
NCT04846634Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043)
NCT02332499Study of Anlotinib in Patients With Metastatic Colorectal Cancer(mCRC)(ALTER0703)
NCT04768699Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia.
NCT06662773Drug-Drug Interaction (DDI) Study for TQB3616
NCT06469879A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung Cancer Patients
NCT04080843Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients
NCT06851442Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer
NCT07338838To Evaluate the Tolerability and Pharmacokinetics of TQB3142 for Injection in Patients With Advanced Malignant Tumors
NCT05046847A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3811 Tablets in Patients With Advanced Malignant Tumors
NCT04344158A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
NCT03460457Tolerance and Pharmacokinetics of TQB2450
NCT06431490A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
NCT01833923A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics
NCT07794111A Clinical Trial of TQF6422 Injection in Overweight or Obese Healthy Subjects.
NCT04325763A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC)
NCT04385563A Study to Evaluate the Efficacy and Safety of the Combination of TQ-B211 Plus Docetaxel in Patients With HER2-positive MBC.
NCT05646758A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects
NCT05409326A Study of TQH2722 Injection to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Immunogenicity in Healthy Adult Subjects
NCT07172126Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets
NCT05252078Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients
NCT05292196A Phase II Clinical Trial of TQC3721 Suspension for Inhalation
NCT03750916Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung Cancer
NCT03754244A Phase I Study of TQ-B3456 on Tolerance and Pharmacokinetics
NCT04941404A Study of TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD)
NCT04481607A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3454 Tablets
NCT07047365TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
NCT02622932Study to Investigate the Absorption, Metabolism and Excretion of [14C] Anlotinib in Patients With Advanced Cancer Patients
NCT07398859Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis
NCT06297642TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.
NCT06702618Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer
NCT05028218A Clinical Study of TQB3824 in Subjects With Advanced Cancer
NCT03777085Study of TQB2303 in Patients With CD20-Positive Diffuse Large B-cell Lymphoma (DLBCL)
NCT04306926A Study of TQB2450 Injection Combined With Stereotactic Body Radiation Therapy (SBRT) in Subjects With Advanced Oligometastatic Non-Small Cell Lung Cancer
NCT04619537A Trial of Anlotinib Combined With Docetaxel in Patients With Wild-type Advanced Non-squamous Non Small Cell Lung Cancer
NCT07400406A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance for the Detection of Calcified Coronary Arteries
NCT07406035A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis
NCT04306887A Study of TQ-B3101 in Subjects With Relapsed or Refractory Anaplastic Large Cell Lymphoma (ALCL)
NCT03706287Efficacy and Safety of Anlotinib Plus Platinum Plus Pemetrexed in T790M-negative NSCLC
NCT04408079A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3558 Tablets
NCT02287857Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis B